Daniel Lebovic, MD
Hematology/oncology in Grosse Pointe Woods, MI
About Dr. Daniel Lebovic
Dr. Daniel Lebovic is a physician specializing in hematology/oncology practicing in Grosse Pointe Woods, MI. Affiliated with Corewell Health Beaumont Grosse Pointe Hospital, Henry Ford Health -St John Hospital, Henry Ford Health Hospital and 2 more. Treated 409 Medicare patients in 2024.
| Specialty | Hematology/oncologyOther hematology/oncology doctors in Grosse Pointe Woods |
|---|---|
| Also practices | Internal Medicine, Medical Oncology |
| Credentials | MD |
| Gender | Male |
| NPI number | 1740302850National Provider Identifier (CMS NPPES), issued April 2007 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
| Telehealth | Offers telehealth servicesCMS Doctors and Clinicians |
Where Dr. Daniel Lebovic practices
- Hematology-Oncology Associates East 19229 Mack Ave, Suite 24, Grosse Pointe Woods, MI 48236 (313) 884-5522 · Directions · group of 351 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Daniel Lebovic's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Hematology & Oncology Primary | MI 4301088178 |
| Medical Oncology | MI 4301088178 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Hospital affiliations of Dr. Daniel Lebovic
- Corewell Health Beaumont Grosse Pointe HospitalHospital · Grosse Pointe, MI
- Henry Ford Health -St John HospitalHospital · Detroit, MI
- Henry Ford Health HospitalHospital · Detroit, MI
- Henry Ford Health Macomb HospitalHospital · Clinton Township, MI
- Henry Ford Health Warren HospitalHospital · Warren, MI
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Daniel Lebovic's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 572 | $98.17 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 268 | $16.58 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 255 | $67 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 112 | $79.46 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 74 | $174.70 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 44 | $131.93 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 20 | $119.31 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $35.37 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Daniel Lebovic's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as apm. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Daniel Lebovic (2025)
$21,430.68 in 20 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Compensation for services other than consulting | 7 | $20,889 |
| Food and beverage | 12 | $335.88 |
| Travel and lodging | 1 | $205.80 |
Paying companies: Genzyme Corporation ($13,993.18), PharmaEssentia USA Corporation ($7,245), GlaxoSmithKline, LLC. ($119.63), Genentech USA, Inc. ($34.48), Gilead Sciences, Inc. ($22.89), Servier Pharmaceuticals LLC ($15.50).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Daniel Lebovic
What kind of clinician is Dr. Daniel Lebovic?
Dr. Daniel Lebovic is listed as a physician specializing in hematology/oncology, also practicing internal medicine, medical oncology.
Where does Dr. Daniel Lebovic practice?
Hematology-Oncology Associates East at 19229 Mack Ave, Suite 24, Grosse Pointe Woods, MI 48236.
What is the office phone number for Dr. Daniel Lebovic?
The listed office number is (313) 884-5522. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Daniel Lebovic?
The National Provider Identifier is 1740302850.
Does Dr. Daniel Lebovic accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Daniel Lebovic affiliated with?
Corewell Health Beaumont Grosse Pointe Hospital, Henry Ford Health -St John Hospital, Henry Ford Health Hospital, Henry Ford Health Macomb Hospital, Henry Ford Health Warren Hospital.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2018-05-31 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.